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Since the publication of this article [1], we have been
made aware of two errors in the manuscript.
First, it was reported that 344 participants were allo-
cated to one of two groups. This was a typo consistent
throughout the article, and should have been 334 (168
intervention, 166 control – which was reported correctly).
Secondly, the RR calculation was based on the trans-
posed table, which produced the correct p value and
OR, but incorrect RR (1.38 instead of 1.51). As such, it
was reported that: “those sent the personalised email
were 1.5 times (95 % CI = 1.18–1.93) more likely to re-
spond than those sent the generic email.” This should
have read: “those sent the personalised email were 1.4
times (95 % CI = 1.15–1.66) more likely to respond than
those sent the generic email.”
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